8THINTERNATIONAL CONFERENCE ON THORACIC ONCOLOGY - VIRTUAL FORMAT June 25TH - 26TH 2020 - Fad ...
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
8TH INTERNATIONAL CONFERENCE ON THORACIC ONCOLOGY VIRTUAL FORMAT June 25 TH - 26 TH 2020
PRESIDENT OF THE CONFERENCE
Filippo de Marinis
SCIENTIFIC & ORGANIZING COMMITTEE
AIOT Board
Fortunato Ciardiello
Filippo de Marinis
Cesare Gridelli
Rossella Spinetti
Lucio Crinò
Marina Chiara Garassino
Nicola Normanno
Lorenzo Spaggiari
Under the auspices of
WELCOME FROM THE PRESIDENT
Dear Collegue, Goals
Setted immediately after ASCO, the Conference
it’s my great pleasure to invite you to partecipate in the will give an update on the data coming from Clinical
proceedings of 8th International Conference on Research in Thoracic Oncology directly from the voice
Thoracic Oncology (CIOT) that, in its annual recurrence, of its Authors more representative in an appointment
will take place in Virtual Format for the first time, from that we would like to be lasting inside of the international
June 25th to June 26th 2020 organized by AIOT (Italian congressional track.
Association of Thoracic Oncology) and that I’ve the
responsibility to chair. For these reasons I’m trusting that you should
appreciate the effort of the organizing secretariat to
I would like to call your attention to at least three realize this scientific meeting doing credit to us with
interesting aspects of the Conference that make the your attendance in our website.
appointment very peculiar and that I identify in its
International form, in the virtual format and in its goals. Arrivederci
International form
The 70% of Faculty is composed of foreign President of 8th CIOT
speakers, everybody playing an active part in clinical Filippo de Marinis
research in Thoracic Oncology and KOL in their
respective countries. We expect significant foreign
attendees. The official language of the Conference will
be English.
Virtual Format
For the first time, due to the emergency of
COVID-19, the 8th International Conference on
Thoracic Oncology will take place in virtual format to
provide clinicians all over the world with access to the
contributions.
SCIENTIFIC INFORMATION
PROGRAMMA DI FORMAZIONE A DISTANZA ISTRUZIONI
ACCREDITATO PRESSO LA CNFC 1 - REGISTRAZIONE
I crediti ECM per questo programma FAD sono Accedere all’indirizzo
rilasciati da SOS Srl Scientific Organizing Service, www.scientificorganizingservice.com/fad,
provider FAD nazionale accreditato con n. 1080 a registrarsi per collegarsi e usufruire del percorso
fornire programmi di formazione continua per gli formativo.
operatori sanitari. SOS Srl si assume la responsabilità
dei contenuti, la qualità e la correttezza etica di questa 2 - TEST DI VALUTAZIONE DELL’APPRENDIMENTO
attività ECM. Terminato lo studio, sarà necessario completare il
test di valutazione dell’apprendimento entro 3 giorni
DURATA DEL PROGRAMMA dalla data di svolgimento con la possibilità di
dal 25 al 26 giugno 2020 rivedere il webinar. Tale test può essere ripetuto al
massimo 5 volte e viene superato completando
PROFESSIONI ACCREDITATE correttamente il 75% dei quesiti proposti.
8TH CIOT partecipa al programma ECM con
l’accreditamento delle seguenti figure professionali: 3 - CERTIFICATO DI ACQUISIZIONE CREDITI
Superato il test è possibile visualizzare e scaricare il
• Biologi; certificato di attribuzione dei crediti ECM in formato
PDF.
• Medici Chirurghi per le discipline di: Anatomia
Patologica, Chirurgia Toracica, Malattie HELP DESK
dell’Apparato Respiratorio, Medicina Generale (attivo dal 25 al 29 giugno 2020): Per qualsiasi
(medici di famiglia), Medicina Interna, Oncologia, necessità l’utente può contattare SOS S.r.l., il provider
Radiodiagnostica, Radioterapia. che cura l’iniziativa.
Assistenza Tecnica: Francesco Cicolani
OBIETTIVO FORMATIVO Tel. (+39) 3288852138 - E-mail: cicolani@flyonweb.it
1 - Applicazione nella pratica quotidiana dei principi e
delle procedure dell'evidence based practice Per altre informazioni restano contattabili i numeri
(EBM - EBN - EBP) della Segreteria Organizzativa.
CREDITI EROGATI
9 crediti complessivi
Durata prevista dell’attività formativa: 9 ore
Servizio scientifico realizzato per l’aggiornamento
della Classe Medica con il sostegno di grant
educazionale non condizionante delle Aziende
indicate.
REGISTRATIONS GUIDELINES Attendees, wishing to attend the conference without issuing credits, will be able to connect to the platform www.scientificorganizingservice.com/fad and enter as guest by downloading, in this case at the end of the course, the certificate of participation.
PROGRAMME
June 25TH, 2020 THURSDAY
15.00 – 15.10 WELCOME AND INTRODUCTION TO THE TARGET DAY
Filippo de Marinis (Milan, IT)
15.10 – 15.30 KEYNOTE LECTURE
TISSUE IS STILL THE ISSUE IN NGS COMING ERA?
Tony Mok (Hong Kong, HK)
SESSION 1
Chair: Lucio Crinò (Meldola, IT)
15.30 – 15.50 EGFR-positive disease: from 3rd generation TKI to the
combination approach
Suresh Ramalingam (Atlanta, US)
15.50 – 16.10 Looking for the optimal sequence in ALK-positive NSCLC
Enriqueta Felip (Barcelona, ES)
16.10 – 16.30 Hitting the target in ROS1 rearranged disease
Stephen V. Liu (Washington, US)
16.30 – 16.50 CommentsSESSION 2
Chair: Nicola Normanno (Naples, IT)
16.50 – 17.10 Recent advances for the treatment of uncommon EGFR mutation
James Yang (Taiwan, CN)
17.10 – 17.30 MET and BRAF: where are we going?
David Planchard (Paris, FR)
17.30 – 17.50 Understanding the upcoming new targets (KRAS and RET)
Shirish Gadgeel (Ann Arbor, US)
17.50 – 18.10 Comments
Conclusion Day 1June 26TH, 2020 FRIDAY
10.00 – 10.10 INTRODUCTION OF THE IMMUNO-ONCOLOGY DAY
Fortunato Ciardiello (Naples, IT)
10.10 – 10.30 KEYNOTE LECTURE
THE NEW FRONTIERS OF IMMUNO-ONCOLOGY
AND PRECISION MEDICINE
Solange Peters (Lausanne, CH)
SESSION 3
Chair: Cesare Gridelli (Avellino, IT)
10.30 – 10.50 ICIs in 1L of NSCLC with PD-L1 ≥ 50% (IO vs IO + chemo vs IO+IO + chemo)
Luis Paz Ares (Madrid, ES)
10.50 – 11.10 ICIs in 1L of NSCLC with PD-L1SESSION 4
Chair: Lorenzo Spaggiari (Milan, IT)
13.30 – 13.50 Which role for adjuvant & neoadjuvant ICIs in NSCLC?
Raffaele Califano (Manchester, UK)
13.50 – 14.10 The evolving role of Immunotherapy in locally advanced NSCLC
David Planchard (Paris, FR)
14.10 – 14.30 Immunotherapy in SCLC
Stephen V. Liu (Washington, US)
14.30 – 14.50 Comments
SESSION 5
Chair: Marina Garassino (Milan, IT)
14.50 – 15.10 Hyperprogressive Disease
Stéphane Champiat (Paris, FR)
15.10 – 15.30 Immunotherapy in oncogene-addicted lung cancer
Fabrice Barlesi (Marseilles, FR)
15.30 – 15.50 Resistance Mechanisms to Immunotherapy
Shirish Gadgeel (Ann Arbor, US)
15.50 – 16.10 Is there an optimal duration of ICIs in NSCLC?
Suresh Ramalingam (Atlanta, US)
16.10 – 16.30 Comments
16.30 – 17.00 Lung guidelines in COVID-19 era
Filippo de Marinis (Milan, IT)
Thanks and Goodbye
Filippo de MarinisNotes
SPONSORSHIP LEVELS PLATINUM SPONSOR GOLD SPONSOR BRONZE SPONSOR OTHER SPONSOR
SCIENTIFIC SECRETARIAT ORGANIZING SECRETARIAT by
AIOT - Associazione Italiana di Oncologia Toracica SOS S.r.l.
Via Salaria, 237 - 00199 Roma Via Salaria, 237 - 00199 Roma
Tel. +(39) 333 65 93 541 - Fax (+39) 06 85 40 679 Tel. (+39) 333 65 93 541 - Fax (+39) 06 85 40 679
oncologiatoracica@yahoo.it - www.oncologiatoracica.it www.scientificorganizingservice.com - rossella.spinetti@alice.itPuoi anche leggere
